• Shop
  • Publish
  • Prints & Productions
  • Learning solutions for businesses
Forgot your password?

I don't have an Acco-account yet and want to register now

Create an account
0
Need help?
accouitgeverij.nl
en
Nederlands English
View all Show all results
0 results in 0 specialist areas
View all 0 results
Course materials
UGent - RevaKi + LO & BW KU Leuven (Leuven en Heverlee) KULAK KU Leuven campus Brugge KU Leuven campus IIW De Nayer Universiteit Gent KU Leuven campus Gent

Specialist literature
  • Medical
  • Literature and fiction
  • Philosophy and religion
  • History
  • Economics and management
  • Law, criminology and notaryship
  • Linguistics
  • Science and technology
  • Travel, recreation and cooking
  • Art and culture
  • Psychology
  • Education and teaching
  • Politics and social sciences
  • Veterinary
  • Office supplies
  • For Students Only

Office supplies
Online printservice
About Acco Shops Buy your Acco share Jobs Customer service Contact

en
Nederlands English
Course materials
UGent - RevaKi + LO & BW KU Leuven (Leuven en Heverlee) KULAK KU Leuven campus Brugge KU Leuven campus IIW De Nayer Universiteit Gent KU Leuven campus Gent
Specialist literature
  • Medical
  • Literature and fiction
  • Philosophy and religion
  • History
  • Economics and management
  • Law, criminology and notaryship
  • Linguistics
  • Science and technology
  • Travel, recreation and cooking
  • Art and culture
  • Psychology
  • Education and teaching
  • Politics and social sciences
  • Veterinary
  • For Students Only
Office supplies Online printservice Gift Voucher
Buy your Acco share
View all Show all results
0 results in 0 specialist areas
View all 0 results
Buy your Acco share
Home Cancer Vaccines

Cancer Vaccines

From Research to Clinical Practice

Adrian Bot Francesco M. Marincola Mihail Obrocea
Cancer research
Book
  • Cancer Vaccines - 9781841848297
€112.89
€107.24 with an Acco share
Estimated time of delivery: 5 to 15 working days
  • with an Acco share you get a discount on Acco-titles, course materials, fiction or non-fiction and office supplies.
Content
With the first therapeutic cancer vaccine approved by the FDA in April 2010, and other vaccines currently in the pipeline, the interest in this developing area is set to increase exponentially. Breaking new grounds,Cancer Vaccines provides a state of the art perspective on a projected, rapidly growing field, and describes the successful journey of the first licensed therapeutic vaccines for cancer, from design to approval. Written and edited by key personnel in industry and academia working within cancer vaccines development, this book is the result of a global collaborative effort integrating industry, academia, non-for profit, with participation from members of regulatory agencies. Key features: * Highlights major vaccines and platform technologies in early or late development, nearing approval * Introduces emerging technologies that could yield novel classes of drugs bridging active and passive immunotherapies * Provides an update of pipeline and approved cancer vaccines * Encompasses both scientific, translational as well as development aspects * Includes an introductory chapter on the immune systems role in cancer and a closing chapter on the challenges involved in cancer vaccine development An essential read for: * Cancer immunologists in academia and industry * Drug developers in the area of oncology biotherapies * Clinical physicians involved in clinical trials of cancer biotherapies * Regulatory agencies CONTENTS 1. 1. Introduction: Cancer vaccines: mechanism and a clinical overview Antoni Ribas and Adrian Bot 2. 2. Revisiting the paradigm on the putative need for antigen-specific responses in cancer Gail D. Sckisel, Julia K. Tietze, and William J. Murphy VACCINE PLATFORMS FOR GENITO-URINARY CANCERS, WITH POTENTIAL APPLICABILITY TO OTHER TUMORS 3. 3. Development of novel immune interventions for genito-urinary cancers Neeraj Agarwal and Nicholas J. Vogelzang 4. 4. Autologous cellular immunotherapy in late-stage prostate cancer: The development history of sipuleucel-T (PROVENGE®) David L. Urdal and Mark W. Frohlich 5. 5. Design, development and translation of poxvirus-based vaccines for cancer Benedetto Farsaci, Anna Kwilas, and James W. Hodge VACCINES FOR SOLID CANCERS AND HEMATOLOGICAL MALIGNANCIES 6. 6. Of mice and men (and dogs!): The first approved cancer therapy vaccine Philip J. Bergman and Jedd D. Wolchok 7. 7. Recombinant protein vaccination for antigen-specific cancer immunotherapy Pedro de Sousa Alves and Vincent Brichard 8. 8. Antigen-targeted, synthetic vaccines for metastatic cancer Zhiyong Qiu, David C. Diamond, Kent A. Smith, Dar Rosario, Sabrina Miles, Mihail Obrocea, Thomas M. Kundig and Adrian Bot 9. 9. Clinical perspectives in cancer vaccines for hematological diseases Maurizio Chiriva-Internati, Leonardo Mirandola, Marjorie Jenkins, Martin Cannon, Everardo Cobos, and W. Martin Kast 10. Epitope-based vaccines for cancer Vy Phan-Lai, Denise L. Cecil, Gregory E. Holt, Daniel R. Herendeen, Forrest Kievit, Miqin Zhang, and Mary L. Disis VACCINE DEVELOPMENT: TRIAL DESIGN AND IMMUNE ASSAYS 11. 11. Emerging clinical trial design concepts for therapeutic cancer vaccines Christina Musselli, Leah Isakov, and Kerry Wentworth 12. 12. T-cell immune monitoring assays to guide the development of new cancer vaccines Cedrik M. Britten, Sylvia Janetzki, Cecile Gouttefangeas, Marij J.P. Welters, Michael Kalos, Christian Ottensmeier, Axel Hoos, and Sjoerd H. van der Burg 13. 13. A biomarker-based, systems biology approach guiding the development of active immunotherapies and immune monitoring Glenda Canderan, Peter Wilkinson, John Schatzle, Mark Cameron, and Rafick-Pierre Sékaly EMERGING NEW VACCINE STRATEGIES, TARGETS, AND ADJUVANTS 14. 14. Targeting regulatory T cells and other strategies to enable cancer vaccines Christopher Paustian, Shawn M. Jensen, Sarah Church, Sachin Puri, Chris Twitty, Hong-Ming Hu, Brendan D. Curti, Walter J. Urba, Raj K. Puri and Bernard A. Fox 15. 15. Molecular targeting of cancer stem cells Zhenhua Li, Debraj Mukherjee, Jang-Won Lee, and John S. Yu 16. 16. RNA in cancer vaccine therapy Smita Nair, David Boczkowski, Scott Pruitt, and Johannes Urban 17. 17. Induction of innate immunity by nucleic acids: A potential adjuvant for cancer vaccines? Bo Jin and Anthony E.T. Yeo NEXT-GENERATION HYBRID ACTIVE/PASSIVE IMMUNOTHERAPIES 18. 18. Passive immunotherapy by T cell-engaging bispecific antibodies Patrick A. Baeuerle and Benno Rattel 19. 19. Antibodies to peptide-HLA complexes have potential application for cancer diagnosis and therapy Jon A. Weidanz and William H. Hildebrand
Specifications
Publisher
Taylor & Francis Ltd
Publication date
August 23, 2011
Pages
244
ISBN
9781841848297
Format
Hardback

More titles in this specialist area

DNA Repair in Cancer Therapy
DNA Repair in Cancer Therapy
Mark R. Kelley
€110.24
€104.72 with an Acco share
This product is not available
DNA Repair in Cancer Therapy
Gene Therapy of Cancer
Gene Therapy of Cancer
Edmund C. Lattime Stanton L. Gerson
€166.02
€157.71 with an Acco share
This product is not available
Gene Therapy of Cancer
Cancer Theranostics
Cancer Theranostics
Stephen Wong Xiaoyuan Chen
€166.02
€157.71 with an Acco share
This product is not available
Cancer Theranostics
Advances in Cancer Research: Volume 121
Advances in Cancer Research: Volume 121
Kenneth D. Tew Paul B. Fisher
€138.13
€131.22 with an Acco share
This product is not available
Advances in Cancer Research: Volume 121
Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging
Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging
M. Hayat
€169.90
€161.40 with an Acco share
This product is not available
Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging
Molecular Biology of Cancer
Molecular Biology of Cancer
Lauren Pecorino
€49.60
€47.12 with an Acco share
This product is not available
Molecular Biology of Cancer

Do you have a question?

Our customer service is happy to help. Consult our frequently asked questions or contact us.

This item is being added to your cart
This item has been added to your cart
This product is already in your shopping cart
To cart
Keep me informed
Your email address has been noted.
We will inform you when this item is available again.
Book condition
An important factor of a second-hand book is the condition of the book. The buyer may not be surprised. Always mention damages or defects. We use a system with 3 stars:
The book is acceptable: you have used it to study and made notes and markings – but everything is still readable. The cover and pages are in good condition.
The book still looks good: there are a few notes in it and you marked it. There are hardly any signs of use on the cover and pages.
The book is (almost) new: you have not written or marked in it. There are no signs of use on the cover and pages.

Newsletter

Stay informed with the latest news from Acco

Stay up-to-date with our latest news. You can read more about how we process your data in our privacy policy.
Acco 2025 • Terms and conditions • Privacy policy • Cookie settings
BE 0403 547 615
facebook linkedin instagram
BE 0403 547 615

De Smidse, Sluisstraat 10, 3000 Leuven

Map
You need a code for this download
Your code is incorrect.
Log in
Forgot your password?
Not registered yet?

Register to buy or link an Acco share and buy your books and supplies at reduced rates. Registering is also required to download certain files.

Sign up